Press Release – medac at the BAD meeting 2017

Update on the first-line agent Methotrexate in psoriasis treatment: Intensified dosing and subcutaneous administration recommended British Association of Dermatologists’ guidelines reaffirms the importance of the well- established and inexpensive first-line systemic agent Methotrexate (MTX) for the treatment of patients with all types of psoriasis Recently in The Lancet published METOP trial meets the need of […]

Press Release – medac passes eco-audit

medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]

EADV 2016 – METOP study in medac satellite symposium

Benefits for psoriasis practices: New phase III data shows subcutaneous methotrexate’s favorable long-term efficacy and safety profile. Medac hosted  a satellite symposium at the EADV conference 2016 in Vienna with the title METOP study – evaluation of subcutaneous methotrexate for psoriasis patients. Satellite symposium took place on Friday 30th of September, 2016 at Hall L3, floor […]

EULAR 2016 – medac satellite symposium

Medac hosts a Satellite symposium at the EULAR conference 2016 in London, with the title Best practice and future perspective of subcutaneous methotrexate. This will take place on Thursday the 9th of June 2016 at 8.15 am – 9.45, Room Capital Suite 2/4. EULAR invitation medac press release EULAR 2016 More information about the congress  

Yhteistyö terveydenhuollon ammattilaisten kanssa

Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2015 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2016 Taloudellisten tietojen julkistaminen – medac GmbH sivuliike Suomessa 2017 Muistio julkistamisessa käytetyistä menetelmistä Ex post facto done essay writer after another thing, and operating retroactively.